China Grand Pharmaceutical and Healthcare Holdings Limited 遠 大 醫 藥 健 康 控 股 有 限 公 司 * CONTINUING CONNECTED TRANSACTIONS

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "China Grand Pharmaceutical and Healthcare Holdings Limited 遠 大 醫 藥 健 康 控 股 有 限 公 司 * CONTINUING CONNECTED TRANSACTIONS"

Transcription

1 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. China Grand Pharmaceutical and Healthcare Holdings Limited 遠 大 醫 藥 健 康 控 股 有 限 公 司 * (incorporated in Bermuda with limited liability) (Stock Code: 00512) CONTINUING CONNECTED TRANSACTIONS CONTINUING CONNECTED TRANSACTIONS The Board announces that on 23 October 2015, the Group entered into the CCT Agreements, pursuant to which: (1) Grand Pharm (China) or its related companies will supply pharmaceutical preparations and raw materials to Huadong Medicine or its related companies; (2) Zhejiang Xianle or its related companies will purchase raw materials for steroid hormones and intermediates from Jiangsu Xin Yi; and (3) Zhejiang Xianle or its related companies will purchase raw materials for steroid hormones and intermediates from Grand Group Corporation. As at the date of this announcement, Mr. Hu is the sole shareholder of Outwit, which is a substantial shareholder of the Company. Mr. Hu, through its control and ultimate beneficial ownership of the entire registered capital of China Grand, indirectly controls the exercise of 30% or more of the voting power at the general meeting of each of Huadong Medicine, Jiangsu Xin Yi and Grand Group Corporation. Accordingly, each of Huadong Medicine, Jiangsu Xin Yi and Grand Group Corporation is an associate of Mr. Hu, and thus is regarded as a connected person of the Company. Hence the transactions contemplated under the CCT Agreements constitute continuing connected transactions on the part of the Company. As Huadong Medicine, Jiangsu Xin Yi and Grand Group Corporation are connected with each other by virtue of the fact that all of them are associates of Mr. Hu, and the subject matters of each of the CCT Agreements are similar in nature, pursuant to Rule 14A.81 of the Listing Rules, the transactions between the Group and each of these companies would be aggregated. As the aggregated amount of the Grand Pharm Supply Caps and the Xianle Purchase Caps will exceed HK$10,000,000 per annum, the transactions contemplated under the CCT Agreements are subject to the reporting, announcement and Independent Shareholders approval requirements under Chapter 14A of the Listing Rules. 1

2 GENERAL The Independent Board Committee has been formed to advise the Independent Shareholders as to the fairness and the reasonableness of the terms of the CCT Agreements (including but not limited to the Grand Pharm Supply Caps and the Xianle Purchase Caps) and the transactions contemplated respectively thereunder and as to how to vote at the SGM. The Company will appoint an independent financial adviser to advise the Independent Board Committee and the Independent Shareholders in relation to the CCT Agreement and the transactions contemplated respectively thereunder. The transactions contemplated under the CCT Agreements are subject to the annual review requirement pursuant to Rules 14A.55 to 14A.59 of the Listing Rules. The SGM will be convened at which the Independent Shareholders will consider and, where appropriate, approve the CCT Agreements (including but not limited to the Grand Pharm Supply Caps and the Xianle Purchase Caps) and the transactions respectively contemplated thereunder. A circular containing, amongst other things, further information on the CCT Agreements together with a letter of advice from the Independent Board Committee to the Independent Shareholders, a letter of advice from the independent financial adviser to the Independent Board Committee and the Independent Shareholders and the notice of the SGM will be despatched to the Shareholders on or before 13 November BACKGROUND Reference is made to the announcements of the Company dated 28 November 2012 and 21 December 2012, and the circular of the Company dated 28 January 2013 in relation to, among other things, certain continuing connected transactions of the Company. As mentioned in the Company s circular dated 28 January 2013, on 28 November 2012, the Group entered into, among other things, the following agreements which constituted continuing connected transactions of the Company: (1) a supply agreement under which Grand Pharm (China) or its related companies would supply pharmaceutical preparations, raw materials and technologies to Huadong Medicine or its related companies; (2) a purchase agreement under which Zhejiang Xianle or its related companies would purchase raw materials for steroid hormones and intermediates from Jiangsu Xin Yi; and (3) a purchase agreement under which Zhejiang Xianle or its related companies would purchase raw materials for steroid hormones and intermediates from Grand Group Corporation. These three agreements expired on 31 December

3 With a view to continuing the purchase/supply arrangements with the aforesaid parties which are in alignment with the current development of the Group, on 23 October 2015 the Group entered into the new CCT Agreements with the aforesaid parties on terms which are disclosed in this announcement. RELATIONSHIPS BETWEEN THE PARTIES To the best of the Directors knowledge, information and belief and having made all reasonable enquiries, the relationships between the relevant parties under the CCT Agreements are set out below: The Group The Company Grand Pharm (China) Zhejiang Xianle China Grand Pharmaceutical and Healthcare Holdings Limited ( 遠 大 醫 藥 健 康 控 股 有 限 公 司 * ), a company incorporated in Bermuda with limited liability with its issued Shares listed on the Stock Exchange Grand Pharmaceutical (China) Company Limited # ( 遠 大 醫 藥 ( 中 國 ) 有 限 公 司 ), a company established under the laws of the PRC and is an indirect non-wholly owned subsidiary of the Company Zhejiang Xianju Xianle Pharmaceutical Company Limited # ( 浙 江 仙 居 仙 樂 藥 業 有 限 公 司 ), a company established under the laws of the PRC and is owned as to approximately 67% by the Company and as to approximately 33% by Independent Third Parties Parties outside the Group Mr. Hu Outwit China Grand Ideal Group Grand Group Corporation Huadong Medicine Mr. Hu Kaijun, being the sole shareholder of Outwit a substantial shareholder of the Company, which is interested in 62.63% of the total issued share capital of the Company China Grand Enterprises Incorporation # ( 中 國 遠 大 集 團 有 限 責 任 公 司 ), a company established under the laws of the PRC and is owned as to (i) approximately 51% by Beijing Yuan Da, and (ii) approximately 49% by Beijing Yan Huang, both companies are controlled and ultimately and beneficially owned by Mr. Hu Lianyungang Ideal Group Co., Ltd # ( 連 雲 港 如 意 集 團 股 份 有 限 公 司 ), a company established under the laws of the PRC and is owned as to approximately 37.08% by China Grand and approximately 62.92% by Independent Third Parties Grand Group Corporation Limited # ( 遠 大 物 產 集 團 有 限 公 司 ), a company established under the laws of the PRC and is owned as to approximately 52% by Ideal Group and as to approximately 48% by Independent Third Parties Huadong Medicine Co., Ltd # ( 華 東 醫 藥 股 份 有 限 公 司 ), a company established under the laws of the PRC and is owned as to approximately 35.5% by China Grand and as to approximately 64.5% by Independent Third Parties 3

4 Jiangsu Xin Yi Jiangsu Grand Xin Yi Pharmaceutical Co., Ltd. # ( 江 蘇 遠 大 信 誼 藥 業 有 限 公 司 ) (formerly known as Yan Cheng Xin Yi Pharmaceutical Chemical Limited # ( 鹽 城 信 誼 醫 藥 化 工 有 限 公 司 )), a company established under the laws of the PRC and is owned as to approximately 67% by China Grand and approximately 33% by an Independent Third Party The chart below illustrates the connections between the relevant parties (entities in shades are parties to the CCT Agreements): Outside the Group The Group China Grand Enterprises (HK) Limited Mr. Hu 10% 35% 100% 100% 珠 海 海 灣 大 酒 店 (Zhu Hai Hai Wan Hotel # ) 80% 90% Outwit 65% 20% 62.63% Beijing Yan Huang Beijing Yuan Da The Company 49% 51% 99.84% 67% China Grand Grand Pharm (China) Zhejiang Xianle 67% 37.08% 35.5% Jiangsu Xin Yi Ideal Group Huadong Medicine 52% Grand Group Corporation CONTINUING CONNECTED TRANSACTIONS (I) Grand Pharm Supply Agreement Date: 23 October 2015 Parties: Products: Grand Pharm (China), as supplier Huadong Medicine, as purchaser Grand Pharm (China) or its related companies shall supply pharmaceutical preparations and raw materials to Huadong Medicine or its related companies. The parties shall determine the specifications, technical requirements, price and volume of the products supplied on an order-by-order basis. 4

5 Pricing basis: Payment terms: Term: Annual cap: The price of the products will be determined on an arm s length basis in the ordinary course of business and on normal commercial terms with reference to the prevailing market prices, or on terms not less favourable than those which will be charged by Grand Pharm (China) or its related companies (if any) to other independent customers for the same or similar products. For the purpose of ascertaining the market prices, the Group will make reference to the latest price which the Group charges for products of comparable quality, quantity and specifications which are supplied to Independent Third Parties. The fees chargeable by the Group will be satisfied in cash. A credit period of 90 days will be given after delivery. For the period commencing from the Effective Date until 31 December Based on the Grand Pharm Supply Agreement, the annual caps of the amount of products to be sold by Grand Pharm (China) or its related companies to Huadong Medicine or its related companies for each of the periods commencing on the Effective Date until 31 December 2015 and for the two years ending 31 December 2017 are RMB22.0 million, RMB25.0 million and RMB29.0 million respectively. (II) Xianle Purchase Agreement I Date: 23 October 2015 The above annual caps are determined by the Directors based on (i) the historical amount of products purchased by Huadong Medicine; and (ii) the estimated maximum orders to be placed to Grand Pharm (China) or its related companies as indicated by Huadong Medicine or its related companies. Parties: Products: Jiangsu Xin Yi, as supplier Zhejiang Xianle, as purchaser Zhejiang Xianle or its related companies shall purchase raw materials for steroid hormones and intermediates from Jiangsu Xin Yi or its related companies. The parties shall determine the specifications, price and volume of the products to be supplied on an order-by-order basis. Pricing basis: The price of the products will be determined on an arm s length basis in the ordinary course of business and on normal commercial terms with reference to the prevailing market prices, or on terms not less favourable than those will be paid by Zhejiang Xianle or its related companies (if any) to other independent suppliers for the same or similar products. For the purpose of ascertaining the market prices, the 5

6 Group will obtain and compare the quotations from two Independent Third Parties for products of comparable quality, quantity and specifications. Payment terms: Term: Annual cap: The purchase price will be satisfied in cash. A credit period of 90 days will be provided after delivery. For the period commencing from the Effective Date until 31 December Based on the Xianle Purchase Agreement I, the annual caps of the products to be purchased from Jiangsu Xin Yi or its related companies for each of the periods commencing on the Effective Date until 31 December 2015 and the two years ending 31 December 2017 are RMB80.0 million, RMB100.0 million and RMB100.0 million respectively. (III) Xianle Purchase Agreement II Date: 23 October 2015 The above annual caps are determined by the Directors based on (i) the completed expansion of production capacity of Zhejiang Xianle and its subsidiary in 2014; (ii) the new steroid hormones products of the Group having obtained a GMP certificate in the first half of 2015 and has commenced trial production in the second half of 2015; (iii) the historical amount of products purchased from Jiangsu Yin Xi; and (iv) the future expansion of the business and the developing strategy of the Group. Parties: Products: Grand Group Corporation, as supplier Zhejiang Xianle, as purchaser Zhejiang Xianle or its related companies shall purchase raw materials for steroid hormones and intermediates from Grand Group Corporation or its related companies. The parties shall determine the specifications, price and volume of the products to be supplied on an order-by-order basis. Pricing basis: The price of the products will be determined on an arm s length basis in the ordinary course of business and on normal commercial terms with reference to the prevailing market prices, or are on terms not less favourable than those will be paid by Zhejiang Xianle or its related companies (if any) to other independent suppliers for the same or similar products. For the purpose of ascertaining the market prices, the Group will obtain and compare the quotations from two Independent Third Parties for products of comparable quality, quantity and specifications. 6

7 Payment terms: Term: Annual cap: The purchase price will be satisfied in cash. A credit period of 90 days will be provided after delivery. For the period commencing from the Effective Date until 31 December Based on the Xianle Purchase Agreement II, the annual caps of the amount of products to be purchased from Grand Group Corporation or its related companies for each of the periods commencing on the Effective Date until 31 December 2015 and the two years ending 31 December 2017 are RMB8.0 million, RMB10.0 million and RMB10.0 million respectively. Common terms of the CCT Agreements The above annual caps are determined by the Directors based on (i) the completed expansion of production capacity of Zhejiang Xianle and its subsidiary in 2014; (ii) the new steroid hormones products of the Group having obtained a GMP certificate in the first half of 2015 and has commenced trial production in the second half of 2015; (iii) the historical amount of products purchased from Grand Group Corporation; and (iv) the future expansion of the business and the developing strategy of the Group. Each of the CCT Agreements contains the following terms: 1. The terms of each of the CCT Agreements shall become effective on the date (the Effective Date ) falling upon the passing of the relevant resolutions by the Independent Shareholders at the SGM and expire on 31 December The Group will be entitled to extend the CCT Agreements on or before 31 December 2017 and to take such action as may be appropriate to comply with the Listing Rules. Without prejudice to the right of any parties to terminate the CCT Agreements pursuant to their respective terms, the CCT Agreements shall be automatically terminated before 31 December 2017 (or such later date as the parties to the respective agreement may agree) if, among other things: (i) (ii) the Group consider that it is not feasible to comply with the Listing Rules at the relevant time; or compliance with the Listing Rules would require changes to the CCT Agreements which are not acceptable to any of the parties. 2. All changes made to the CCT Agreements shall be subject to compliance by the Company with the Listing Rules. 3. The total annual consideration payable or receivable by the Group under the CCT Agreements shall be subject to an annual cap agreed by the parties. 4. The CCT Agreements will supersede and replace the previous agreements entered into between the relevant parties (if any) upon the CCT Agreements becoming effective on 7

8 the Effective Date. INFORMATION ABOUT THE GROUP AND THE COUNTERPARTIES The Group, including its PRC subsidiaries, is mainly engaged in the research and development, manufacturing and sales of pharmaceutical preparations, pharmaceutical intermediates, specialised pharmaceutical raw materials and healthcare products. Huadong Medicine and its subsidiaries are principally engaged in the manufacture and sale of pharmaceutical products. Jiangsu Xin Yi and its subsidiaries are principally engaged in the manufacture and sale of pharmaceutical products and raw materials. Grand Group Corporation and its subsidiaries are principally engaged in the logistic, trading and investment, including but not limited to the export and import of pharmaceutical products and raw materials. REASONS FOR ENTERING INTO THE CONTINUING CONNECTED TRANSACTIONS The Group will sell and/or supply to Huadong Medicine (i) various medicines, such as cerebro-cardiovascular medicines and antibiotics; and (ii) certain pharmaceutical intermediates, which are chemicals and raw materials for the production of its own products. As Huadong Medicine has developed its own sales network and retail stores in many cities in the PRC, which cover over ten provinces, the Directors (excluding the independent non-executive Directors who shall provide their views after taking the advice from the independent financial adviser) are of the view that the entering into of the Grand Pharm Supply Agreement may allow the Group to make use of the existing sales network of Huadong Medicine and to promote our product brands through such sales network. The entering into of the Xianle Purchase Agreements can maintain merchantable products quality and a constant supply of raw materials, which are beneficial to implement the Group s business strategy and to reduce its operation risks. In view of the above, the Directors (excluding the independent non-executive Directors who shall provide their views after taking the advice from the independent financial adviser) consider that the entering into of the CCT Agreements are in the ordinary course of business of the Group and that the terms of such agreements are determined on an arm s length basis among the relevant parties and that the terms and conditions of the CCT Agreements are fair and reasonable and in the interests of the Company and the Shareholders as a whole. IMPLICATIONS UNDER THE LISTING RULES As at the date of this announcement, Mr. Hu is the sole shareholder of Outwit, which is a substantial shareholder of the Company. Mr. Hu, through its control and ultimate beneficial ownership of the entire registered capital of China Grand, indirectly controls the exercise of 30% or more of the voting power at the general meeting of each of Huadong Medicine, Jiangsu Xin Yi and Grand Group Corporation. Please refer to the paragraph headed 8

9 Relationships between the parties for further details of the shareholding structure. Accordingly, each of Huadong Medicine, Jiangsu Xin Yi and Grand Group Corporation is an associate of Mr. Hu, and thus is regarded as a connected person of the Company. Hence the transactions contemplated under the CCT Agreements constitute continuing connected transactions on the part of the Company. As Huadong Medicine, Jiangsu Xin Yi and Grand Group Corporation are connected with each other by virtue of the fact that all of them are associates of Mr. Hu, and the subject matters of each of the CCT Agreements are similar in nature, pursuant to Rule 14A.81 of the Listing Rules the transactions between the Group and each of these companies would be aggregated. As the aggregated amount of the Grand Pharm Supply Caps and the Xianle Purchase Caps will exceed HK$10,000,000 per annum, the transactions contemplated under the CCT Agreements are subject to the reporting, announcement and Independent Shareholders approval requirements under Chapter 14A of the Listing Rules. In accordance with the Listing Rules, Mr. Hu, Outwit and their respective associates will abstain from voting on the resolutions to approve the CCT Agreements and any vote exercised by the Independent Shareholders at the SGM shall be taken by poll. Save as disclosed above, no Shareholder has a material interest in the CCT Agreements that is required to abstain from voting on the relevant resolutions at the SGM. GENERAL The Independent Board Committee comprising Ms. So Tosi Wan, Winnie, Mr. Lo Kai Lawrence and Dr. Pei Geng, being all independent non-executive Directors, has been formed to advise the Independent Shareholders as to the fairness and the reasonableness of the terms of the CCT Agreements (including the Grand Pharm Supply Caps and the Xianle Purchase Caps) and the transactions contemplated thereunder and as to how to vote at the SGM. The Company will appoint an independent financial adviser to advise the Independent Board Committee and the Independent Shareholders in relation to the CCT Agreements and the transactions contemplated thereunder. The transactions contemplated under the CCT Agreements are subject to the annual review requirement pursuant to Rules 14A.55 to 14A.59 of the Listing Rules. A circular containing, amongst other things, further information on the CCT Agreements together with a letter of advice from the Independent Board Committee to the Independent Shareholders, a letter of advice from the independent financial adviser to the Independent Board Committee and the Independent Shareholders and the notice of the SGM will be despatched to the Shareholders on or before 13 November DEFINITIONS In this announcement, unless the context otherwise requires, the following terms shall have the following meanings: 9

10 associates Beijing Yan Huang Beijing Yuan Da Board CCT Agreements China Grand Company connected person Director(s) Grand Group Corporation has the meaning ascribed to it under the Listing Rules Beijing Yan Huang Zhi Ye Limited # ( 北 京 炎 黃 置 業 有 限 公 司 ), a company established in the PRC with limited liability Beijing Yuan Da Hua Chuang Investment Limited # ( 北 京 遠 大 華 創 投 資 有 限 公 司 ), a company established in the PRC with limited liability the board of Directors collectively, the Grand Pharm Supply Agreement and the Xianle Purchase Agreements China Grand Enterprises Incorporation # ( 中 國 遠 大 集 團 有 限 責 任 公 司 ), a company established in the PRC with limited liability, which is controlled and ultimately and beneficially owned by Mr. Hu China Grand Pharmaceutical and Healthcare Holdings Limited ( 遠 大 醫 藥 健 康 控 股 有 限 公 司 *), a company incorporated in Bermuda with limited liability, and the issued Shares of which are listed on the main board of the Stock Exchange has the meaning ascribed to it under the Listing Rules the director(s) of the Company Grand Group Corporation Limited # ( 遠 大 物 產 集 團 有 限 公 司 ), a company established in the PRC with limited liability, and engaged in various business such as logistics, trading and investment, including the export and import of pharmaceutical products raw materials Grand Pharm (China) Grand Pharmaceutical (China) Company Limited # ( 遠 大 醫 藥 ( 中 國 ) 有 限 公 司 ), a company established in the PRC with limited liability, being an indirect non-wholly owned subsidiary of the Company Grand Pharm Supply Agreement Grand Pharm Supply Caps the agreement entered into between Grand Pharm (China) and Huadong Medicine dated 23 October 2015 in respect of the supply of pharmaceutical preparations and raw materials to Huadong Medicine the annual caps for the transactions contemplated by the Grand Pharm Supply Agreement for each of the periods commencing on the Effective Date until 31 December 2015 and the two years ending 31 December

11 Group Hong Kong the Company and its subsidiaries the Hong Kong Special Administrative Region of the PRC Huadong Medicine Huadong Medicine Co., Ltd # ( 華 東 醫 藥 股 份 有 限 公 司 ), a company established in the PRC with limited liability, and the issued shares of which are listed on the Shenzhen Stock Exchange, and principally engaged in manufacture and sale of pharmaceutical products Independent Board Committee Independent Shareholder(s) Independent Third Party(ies) Jiangsu Xin Yi Listing Rules Mr. Hu Outwit PRC an independent committee of the Board consisting of all independent non-executive Directors, namely Ms. So Tosi Wan, Winnie, Mr. Lo Kai Lawrence and Dr. Pei Geng, established for the purpose of advising the Independent Shareholders as to the fairness and reasonableness of the CCT Agreements and the transactions contemplated respectively thereunder Shareholder(s) other than Mr. Hu, Outwit and their respective associates and Shareholders who are connected to or otherwise associated with Mr. Hu, Outwit or interested in the CCT Agreements any person(s) or company(ies) and their rspective ultimate benficial owner(s) who, to the best of the Directors knowledge, information and belief, having made all reasonable enquiries, are third party(ies) independent of and not connected with the Company or its connected persons Jiangsu Grand Xin Yi Pharmaceutical Co., Ltd # ( 江 蘇 遠 大 信 誼 藥 業 有 限 公 司 ) (formerly known as Yan Cheng Xin Yi Pharmaceutical Chemical Limited # ( 鹽 城 信 誼 醫 藥 化 工 有 限 公 司 )), a company established in the PRC with limited liability, and principally engaged in manufacture and sale of pharmaceutical products raw materials the Rules Governing the Listing of Securities on the Stock Exchange Mr. Hu Kaijun, being the sole shareholder of Outwit, a substantial shareholder of the Company Outwit Investments Limited, a company incorporated in the British Virgin Islands with limited liability, which is a substantial shareholder of the Company holding approximately 62.63% of the total issued Shares the People s Republic of China, which, for the purpose of this announcement, shall exclude Hong Kong, the Macau Special 11

12 Administration Region of the PRC and Taiwan SGM Share(s) Shareholder(s) Stock Exchange Xianle First Purchase Caps Xianle Purchase Agreement I Xianle Purchase Agreement II Xianle Purchase Agreements the special general meeting of the Company to be convened to consider and, if thought fit, approve the CCT Agreements and the transactions contemplated respectively thereunder ordinary share(s) of HK$0.01 each in the share capital of the Company holder(s) of the Share(s) The Stock Exchange of Hong Kong Limited the annual caps for the transactions contemplated by the Xianle Purchase Agreement I for each of the periods commencing from the Effective Date until 31 December 2015 and the two years ending 31 December 2017 the agreement entered into between Zhejiang Xianle and Jiangsu Xin Yi dated 23 October 2015 in respect of the purchase of raw materials for steroid hormones and intermediates from Jiangsu Xin Yi the agreement entered into between Zhejiang Xianle and Grand Group Corporation dated 23 October 2015 in respect of the purchase of raw materials for steroid hormones and intermediates from Grand Group Corporation collectively, the Xianle Purchase Agreement I and the Xianle Purchase Agreement II Xianle Purchase Caps collectively, the Xianle First Purchase Caps and the Xianle Second Purchase Caps Xianle Second Purchase Caps Zhejiang Xianle HK$ RMB the annual caps for the transactions contemplated by the Xianle Purchase Agreement II for each of the periods commencing on the Effective Date until 31 December 2015 and the two years ending 31 December 2017 Zhejiang Xianju Xianle Pharmaceutical Company Limited # ( 浙 江 仙 居 仙 樂 藥 業 有 限 公 司 ), a company established in the PRC with limited liability, being a direct non-wholly owned subsidiary of the Company Hong Kong dollars, the lawful currency of Hong Kong Renminbi, the lawful currency of the PRC % per cent. 12

13 By order of the Board China Grand Pharmaceutical and Healthcare Holdings Limited Liu Chengwei Chairman Hong Kong, 23 October 2015 As at the date of this announcement, the Board comprises four executive directors, namely Mr. Liu Chengwei, Mr. Hu Bo, Dr. Shao Yan and Dr. Zhang Ji and three independent non-executive directors, namely Ms. So Tosi Wan, Winnie, Mr. Lo Kai Lawrence and Dr. Pei Geng. * For identification purpose only. # The English transliteration of the Chinese name(s) in this announcement, where indicated, is included for information purpose only, and should not be regarded as the official English name(s) of such Chinese name(s). 13

China Grand Pharmaceutical and Healthcare Holdings Limited* (Incorporated in Bermuda with limited liability (Stock Code: 00512)

China Grand Pharmaceutical and Healthcare Holdings Limited* (Incorporated in Bermuda with limited liability (Stock Code: 00512) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CHTC FONG S INDUSTRIES COMPANY LIMITED CONTINUING CONNECTED TRANSACTIONS PROCUREMENT AGREEMENT IN RELATION TO PURCHASE OF VALVES

CHTC FONG S INDUSTRIES COMPANY LIMITED CONTINUING CONNECTED TRANSACTIONS PROCUREMENT AGREEMENT IN RELATION TO PURCHASE OF VALVES Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTIONS IN RESPECT OF THE MASTER SUB-CONTRACTING AGREEMENT

CONTINUING CONNECTED TRANSACTIONS IN RESPECT OF THE MASTER SUB-CONTRACTING AGREEMENT Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.

SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

POTENTIAL CONTINUING CONNECTED TRANSACTION - INVESTMENT ADVISORY AND MANAGEMENT AGREEMENT

POTENTIAL CONTINUING CONNECTED TRANSACTION - INVESTMENT ADVISORY AND MANAGEMENT AGREEMENT Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

MAJOR AND CONTINUING CONNECTED TRANSACTIONS (FINANCIAL SERVICES FRAMEWORK AGREEMENT)

MAJOR AND CONTINUING CONNECTED TRANSACTIONS (FINANCIAL SERVICES FRAMEWORK AGREEMENT) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTIONS ENTERING INTO MUTUAL COAL SUPPLY AGREEMENT

CONTINUING CONNECTED TRANSACTIONS ENTERING INTO MUTUAL COAL SUPPLY AGREEMENT Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CHINA BEST GROUP HOLDING LIMITED *

CHINA BEST GROUP HOLDING LIMITED * Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

TCL DISPLAY TECHNOLOGY HOLDINGS LIMITED TCL (Incorporated in Bermuda with limited liability) (Stock Code: 334)

TCL DISPLAY TECHNOLOGY HOLDINGS LIMITED TCL (Incorporated in Bermuda with limited liability) (Stock Code: 334) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CHINASOFT INTERNATIONAL LIMITED 中 軟 國 際 有 限 公 司. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 354)

CHINASOFT INTERNATIONAL LIMITED 中 軟 國 際 有 限 公 司. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 354) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CHINA TING GROUP HOLDINGS LIMITED 華 鼎 集 團 控 股 有 限 公 司

CHINA TING GROUP HOLDINGS LIMITED 華 鼎 集 團 控 股 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

MAJOR TRANSACTIONS IN RELATION TO (1) PROVISION OF FINANCE LEASE; (2) FACTORING FACILITY; (3) PROVISION OF GUARANTEE; AND

MAJOR TRANSACTIONS IN RELATION TO (1) PROVISION OF FINANCE LEASE; (2) FACTORING FACILITY; (3) PROVISION OF GUARANTEE; AND Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CHRISTINE INTERNATIONAL HOLDINGS LIMITED

CHRISTINE INTERNATIONAL HOLDINGS LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTIONS

CONTINUING CONNECTED TRANSACTIONS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Flying Financial Service Holdings Limited

Flying Financial Service Holdings Limited Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CHINA SANJIANG FINE CHEMICALS COMPANY LIMITED 中 國 三 江 精 細 化 工 有 限 公 司

CHINA SANJIANG FINE CHEMICALS COMPANY LIMITED 中 國 三 江 精 細 化 工 有 限 公 司 THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt about any aspect of this Circular or as to the action to be taken, you should consult your licensed securities dealer

More information

MAJOR TRANSACTION FORMATION OF JOINT VENTURE COMPANY

MAJOR TRANSACTION FORMATION OF JOINT VENTURE COMPANY Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

(1) MAJOR TRANSACTION ACQUISITION OF FURTHER EQUITY INTERESTS IN SHANGHAI CP GUOJIAN PHARMACEUTICAL CO., LTD.; AND (2) CHANGE IN USE OF PROCEEDS

(1) MAJOR TRANSACTION ACQUISITION OF FURTHER EQUITY INTERESTS IN SHANGHAI CP GUOJIAN PHARMACEUTICAL CO., LTD.; AND (2) CHANGE IN USE OF PROCEEDS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

NANJING SAMPLE TECHNOLOGY COMPANY LIMITED*

NANJING SAMPLE TECHNOLOGY COMPANY LIMITED* Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

ZHUHAI HOLDINGS INVESTMENT GROUP LIMITED

ZHUHAI HOLDINGS INVESTMENT GROUP LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

DISCLOSEABLE TRANSACTION IN RESPECT OF FINANCE LEASE AGREEMENTS

DISCLOSEABLE TRANSACTION IN RESPECT OF FINANCE LEASE AGREEMENTS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

鳳 凰 衛 視 控 股 有 限 公 司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 02008)

鳳 凰 衛 視 控 股 有 限 公 司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 02008) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

SINO RESOURCES GROUP LIMITED (carrying on business in Hong Kong as Sino Gp Limited) 神 州 資 源 集 團 有 限 公 司

SINO RESOURCES GROUP LIMITED (carrying on business in Hong Kong as Sino Gp Limited) 神 州 資 源 集 團 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

HUAJUN HOLDINGS LIMITED *

HUAJUN HOLDINGS LIMITED * Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

NATIONAL UNITED RESOURCES HOLDINGS LIMITED

NATIONAL UNITED RESOURCES HOLDINGS LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

HUAJUN HOLDINGS LIMITED *

HUAJUN HOLDINGS LIMITED * Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

TOP SPRING INTERNATIONAL HOLDINGS LIMITED

TOP SPRING INTERNATIONAL HOLDINGS LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

(Incorporated in Hong Kong with limited liability) (Stock Code: 291)

(Incorporated in Hong Kong with limited liability) (Stock Code: 291) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

DISCLOSEABLE TRANSACTION PROVISION OF ENTRUSTED LOAN TO ZHONGTIAN SYNERGETIC COMPANY

DISCLOSEABLE TRANSACTION PROVISION OF ENTRUSTED LOAN TO ZHONGTIAN SYNERGETIC COMPANY Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

(Incorporated in Hong Kong with limited liability) (Stock Code: 0270) CONTINUING CONNECTED TRANSACTIONS REVISION OF ANNUAL CAPS FOR TENANCY AGREEMENTS

(Incorporated in Hong Kong with limited liability) (Stock Code: 0270) CONTINUING CONNECTED TRANSACTIONS REVISION OF ANNUAL CAPS FOR TENANCY AGREEMENTS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO BANK DEPOSITS

RENEWAL OF CONTINUING CONNECTED TRANSACTIONS IN RELATION TO BANK DEPOSITS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

INSIDE INFORMATION ISSUE OF OFFER LETTERS

INSIDE INFORMATION ISSUE OF OFFER LETTERS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CITIC Dameng Holdings Limited

CITIC Dameng Holdings Limited Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Gemdale Properties and Investment Corporation Limited 金 地 商 置 集 團 有 限 公 司

Gemdale Properties and Investment Corporation Limited 金 地 商 置 集 團 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

首 長 四 方 ( 集 團 ) 有 限 公 司 * SHOUGANG CONCORD GRAND (GROUP) LIMITED (Incorporated in Bermuda with limited liability) (Stock Code: 730)

首 長 四 方 ( 集 團 ) 有 限 公 司 * SHOUGANG CONCORD GRAND (GROUP) LIMITED (Incorporated in Bermuda with limited liability) (Stock Code: 730) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Peking University Resources (Holdings) Company Limited

Peking University Resources (Holdings) Company Limited Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTIONS INVENTORY CONTROL AGREEMENT AND LOAN AGREEMENT

CONTINUING CONNECTED TRANSACTIONS INVENTORY CONTROL AGREEMENT AND LOAN AGREEMENT Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Shunfeng Photovoltaic International Limited 順 風 光 電 國 際 有 限 公 司. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 01165)

Shunfeng Photovoltaic International Limited 順 風 光 電 國 際 有 限 公 司. (Incorporated in the Cayman Islands with limited liability) (Stock Code: 01165) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONNECTED TRANSACTION INVESTMENT IN SINOPHARM HEALTHCARE FUND L.P.

CONNECTED TRANSACTION INVESTMENT IN SINOPHARM HEALTHCARE FUND L.P. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

首 長 四 方 ( 集 團 ) 有 限 公 司 * SHOUGANG CONCORD GRAND (GROUP) LIMITED (Incorporated in Bermuda with limited liability) (Stock Code: 730)

首 長 四 方 ( 集 團 ) 有 限 公 司 * SHOUGANG CONCORD GRAND (GROUP) LIMITED (Incorporated in Bermuda with limited liability) (Stock Code: 730) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTION PROVISION OF ELECTRONIC PLATFORM FOR SALE OF AVIATION PASSENGER COMPREHENSIVE INSURANCE

CONTINUING CONNECTED TRANSACTION PROVISION OF ELECTRONIC PLATFORM FOR SALE OF AVIATION PASSENGER COMPREHENSIVE INSURANCE Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONNECTED TRANSACTION FORWARD SHARE PURCHASE

CONNECTED TRANSACTION FORWARD SHARE PURCHASE Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS AND CONTINUING CONNECTED TRANSACTIONS - FINANCE LEASE

REVISION OF ANNUAL CAPS FOR CONTINUING CONNECTED TRANSACTIONS AND CONTINUING CONNECTED TRANSACTIONS - FINANCE LEASE Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

JOINT ANNOUNCEMENT CONTINUING CONNECTED TRANSACTIONS PURCHASE OF THE AUTOMATION EQUIPMENT BY XINYI SOLAR

JOINT ANNOUNCEMENT CONTINUING CONNECTED TRANSACTIONS PURCHASE OF THE AUTOMATION EQUIPMENT BY XINYI SOLAR Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

COMBA TELECOM SYSTEMS HOLDINGS LIMITED

COMBA TELECOM SYSTEMS HOLDINGS LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONNECTED TRANSACTION EXTENSION OF LOAN ARRANGEMENT

CONNECTED TRANSACTION EXTENSION OF LOAN ARRANGEMENT Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Logan Property Holdings Company Limited

Logan Property Holdings Company Limited Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

SINOPHARM GROUP CO. LTD. * 國 藥 控 股 股 份 有 限 公 司

SINOPHARM GROUP CO. LTD. * 國 藥 控 股 股 份 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTION: FRAMEWORK AGREEMENT REGARDING INTRA-GROUP FINANCIAL SERVICES

CONTINUING CONNECTED TRANSACTION: FRAMEWORK AGREEMENT REGARDING INTRA-GROUP FINANCIAL SERVICES Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

GOLDBOND GROUP HOLDINGS LIMITED

GOLDBOND GROUP HOLDINGS LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

MelcoLot Limited (Incorporated in the Cayman Islands with limited liability) (Stock Code: 8198)

MelcoLot Limited (Incorporated in the Cayman Islands with limited liability) (Stock Code: 8198) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

RENEWAL OF CONTINUING CONNECTED TRANSACTION FINANCIAL SERVICES AGREEMENT WITH CHINALCO FINANCE

RENEWAL OF CONTINUING CONNECTED TRANSACTION FINANCIAL SERVICES AGREEMENT WITH CHINALCO FINANCE Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

MAJOR TRANSACTION ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL OF CONTINENTAL LAND DEVELOPMENT LIMITED

MAJOR TRANSACTION ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL OF CONTINENTAL LAND DEVELOPMENT LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CHINA LESSO GROUP HOLDINGS LIMITED *

CHINA LESSO GROUP HOLDINGS LIMITED * Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTIONS

CONTINUING CONNECTED TRANSACTIONS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

MELBOURNE ENTERPRISES LIMITED 萬 邦 投 資 有 限 公 司

MELBOURNE ENTERPRISES LIMITED 萬 邦 投 資 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

(Incorporated in the Cayman Islands with limited liability) (Stock Code: 3883) MAJOR TRANSACTION

(Incorporated in the Cayman Islands with limited liability) (Stock Code: 3883) MAJOR TRANSACTION Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

DISCLOSEABLE TRANSACTION ENTRUSTED LOAN AGREEMENT

DISCLOSEABLE TRANSACTION ENTRUSTED LOAN AGREEMENT Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

(incorporated in Hong Kong with limited liability) (Stock Code: 1668) DISCLOSEABLE AND CONNECTED TRANSACTION

(incorporated in Hong Kong with limited liability) (Stock Code: 1668) DISCLOSEABLE AND CONNECTED TRANSACTION Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

(1) DISCLOSEABLE AND CONNECTED TRANSACTION CONSULTING SERVICES AGREEMENT; AND (2) CONTINUING CONNECTED TRANSACTION LOAN TRANSACTION

(1) DISCLOSEABLE AND CONNECTED TRANSACTION CONSULTING SERVICES AGREEMENT; AND (2) CONTINUING CONNECTED TRANSACTION LOAN TRANSACTION Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

GOLDEN EAGLE RETAIL GROUP LIMITED

GOLDEN EAGLE RETAIL GROUP LIMITED The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever

More information

GOLDIN FINANCIAL HOLDINGS LIMITED * (Incorporated in Bermuda with limited liability) (Stock Code: 530)

GOLDIN FINANCIAL HOLDINGS LIMITED * (Incorporated in Bermuda with limited liability) (Stock Code: 530) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Heng Xin China Holdings Limited 恒 芯 中 國 控 股 有 限 公 司 * (Incorporated in Bermuda with limited liability) (Stock Code: 8046)

Heng Xin China Holdings Limited 恒 芯 中 國 控 股 有 限 公 司 * (Incorporated in Bermuda with limited liability) (Stock Code: 8046) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

LUEN THAI HOLDINGS LIMITED (incorporated in the Cayman Islands with limited liability)

LUEN THAI HOLDINGS LIMITED (incorporated in the Cayman Islands with limited liability) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

北 京 發 展 ( 香 港 ) 有 限 公 司 BEIJING DEVELOPMENT (HONG KONG) LIMITED (Incorporated in Hong Kong with limited liability) (Stock Code: 154)

北 京 發 展 ( 香 港 ) 有 限 公 司 BEIJING DEVELOPMENT (HONG KONG) LIMITED (Incorporated in Hong Kong with limited liability) (Stock Code: 154) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Ronshine China Holdings Limited

Ronshine China Holdings Limited Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

MAN SANG INTERNATIONAL LIMITED (Incorporated in Bermuda with limited liability)

MAN SANG INTERNATIONAL LIMITED (Incorporated in Bermuda with limited liability) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Sky Forever Supply Chain Management Group Limited

Sky Forever Supply Chain Management Group Limited Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONNECTED TRANSACTIONS: SOFTWARE EXPANSION AND IMPLEMENTATION AGREEMENTS WITH HAINAN CARES

CONNECTED TRANSACTIONS: SOFTWARE EXPANSION AND IMPLEMENTATION AGREEMENTS WITH HAINAN CARES Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

MAJOR TRANSACTION INVOLVING DISPOSAL OF SALE SHARES AND SALE LOANS AND RESUMPTION OF TRADING

MAJOR TRANSACTION INVOLVING DISPOSAL OF SALE SHARES AND SALE LOANS AND RESUMPTION OF TRADING Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

EXEMPTED CONNECTED TRANSACTION DEEMED DISPOSAL OF INTEREST IN WEIGAO ORTHO

EXEMPTED CONNECTED TRANSACTION DEEMED DISPOSAL OF INTEREST IN WEIGAO ORTHO Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Dalian Wanda Commercial Properties Co., Ltd. (A joint stock limited liability company incorporated in the People s Republic of China)

Dalian Wanda Commercial Properties Co., Ltd. (A joint stock limited liability company incorporated in the People s Republic of China) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Phoenix Healthcare Group Co. Ltd 鳳 凰 醫 療 集 團 有 限 公 司

Phoenix Healthcare Group Co. Ltd 鳳 凰 醫 療 集 團 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

DISCLOSEABLE TRANSACTION SECOND SUPPLEMENTAL LOAN AGREEMENT RELATING TO THE FURTHER EXTENSION OF LOAN FACILITY

DISCLOSEABLE TRANSACTION SECOND SUPPLEMENTAL LOAN AGREEMENT RELATING TO THE FURTHER EXTENSION OF LOAN FACILITY Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Gemini Investments (Holdings) Limited

Gemini Investments (Holdings) Limited Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

TRULY INTERNATIONAL HOLDINGS LIMITED (Incorporated in the Cayman Islands with limited liability)

TRULY INTERNATIONAL HOLDINGS LIMITED (Incorporated in the Cayman Islands with limited liability) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

DISCLOSEABLE TRANSACTIONS FINANCE LEASE AGREEMENTS

DISCLOSEABLE TRANSACTIONS FINANCE LEASE AGREEMENTS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

DISCLOSEABLE TRANSACTION (1) SUPPLEMENTAL AGREEMENT (2) ACQUISITION OF THE ENTIRE EQUITY INTEREST IN THE PROJECT COMPANY

DISCLOSEABLE TRANSACTION (1) SUPPLEMENTAL AGREEMENT (2) ACQUISITION OF THE ENTIRE EQUITY INTEREST IN THE PROJECT COMPANY Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

FREEMAN FINANCIAL CORPORATION LIMITED

FREEMAN FINANCIAL CORPORATION LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

DISCLOSEABLE TRANSACTION RELATING TO THE PROVISION OF LOANS

DISCLOSEABLE TRANSACTION RELATING TO THE PROVISION OF LOANS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

POKFULAM DEVELOPMENT COMPANY LIMITED

POKFULAM DEVELOPMENT COMPANY LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONNECTED AND MAJOR TRANSACTION IN RELATION TO AIRCRAFT FINANCE LEASE

CONNECTED AND MAJOR TRANSACTION IN RELATION TO AIRCRAFT FINANCE LEASE Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

SIM TECHNOLOGY GROUP LIMITED *

SIM TECHNOLOGY GROUP LIMITED * Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

DISCLOSEABLE TRANSACTION FINANCE LEASE ARRANGEMENT AND FACTORING ARRANGEMENT

DISCLOSEABLE TRANSACTION FINANCE LEASE ARRANGEMENT AND FACTORING ARRANGEMENT Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

JINGRUI HOLDINGS LIMITED *

JINGRUI HOLDINGS LIMITED * Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

JINGRUI HOLDINGS LIMITED *

JINGRUI HOLDINGS LIMITED * Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

WALKER GROUP HOLDINGS LIMITED *

WALKER GROUP HOLDINGS LIMITED * Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness

More information

CHINA DEVELOPMENT BANK INTERNATIONAL INVESTMENT LIMITED

CHINA DEVELOPMENT BANK INTERNATIONAL INVESTMENT LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CINDERELLA MEDIA GROUP LIMITED 先 傳 媒 集 團 有 限 公 司

CINDERELLA MEDIA GROUP LIMITED 先 傳 媒 集 團 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTIONS ENTERING INTO TRANSPORTATION SERVICE FRAMEWORK AGREEMENT

CONTINUING CONNECTED TRANSACTIONS ENTERING INTO TRANSPORTATION SERVICE FRAMEWORK AGREEMENT Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Ngai Shun Holdings Limited 毅 信 控 股 有 限 公 司

Ngai Shun Holdings Limited 毅 信 控 股 有 限 公 司 Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

Deed of Settlement in respect of. provision of loan by a subsidiary

Deed of Settlement in respect of. provision of loan by a subsidiary Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

SOCAM Development Limited (Incorporated in Bermuda with limited liability) (Stock Code: 983)

SOCAM Development Limited (Incorporated in Bermuda with limited liability) (Stock Code: 983) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONNECTED TRANSACTION ACQUISITION OF THE 11% EQUITY INTERESTS OF MAANSHAN IRON & STEEL (HONG KONG) LIMITED

CONNECTED TRANSACTION ACQUISITION OF THE 11% EQUITY INTERESTS OF MAANSHAN IRON & STEEL (HONG KONG) LIMITED Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information

CONTINUING CONNECTED TRANSACTIONS

CONTINUING CONNECTED TRANSACTIONS Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness

More information